Roycederm Tea Tree Therapeutic
FDA Label NDC 84710-101

10 label sections · Submitted to the FDA by Guangzhou Meixi Pharmaceuticals Co., Ltd. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Guangzhou Meixi Pharmaceuticals Co., Ltd. for the product Roycederm Tea Tree Therapeutic (NDC 84710-101). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - keep out of reach of children, dosage & administration, inactive ingredient, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.